Ayble Health Raises $16M for Virtual GI Care

Ayble Health has raised an oversubscribed $16 million Series A to expand its AI-enabled virtual gastrointestinal care platform.

What happened

The round was led by Neon, with participation from Unum Ventures, Upfront Ventures, M13, Cleveland Clinic Ventures, DigiTx and Accomplice. Total capital raised is now more than $27 million.

Ayble describes its product as a virtual multidisciplinary GI clinic, combining software and clinical services rather than selling a standalone AI diagnostic tool.

Why it matters

Many digital-health companies are moving away from narrow point solutions toward integrated care models. Gastrointestinal conditions often require ongoing management across diet, behaviour, symptoms and clinical treatment, making them well suited to a multidisciplinary approach.

AI can potentially automate parts of monitoring, personalisation and patient support while clinicians focus on higher-value decisions.

The bigger picture

Healthcare AI is increasingly being embedded inside complete care delivery models. The commercial opportunity may therefore come less from selling hospitals another isolated AI product and more from using software to redesign how specialist care is delivered. Ayble's funding fits that broader shift toward technology-enabled virtual clinics.